Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2021

Jun 3, 2021

31799_dirs_2021-06-03_2e69e694-68bd-400e-8965-3ca81a234217.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2021-06-01

Reporting Person: WRIGHT LISA (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-01 Restricted Stock Unit $ A 1300 Acquired Common Stock (1300) Direct
2021-06-01 Stock Option (right to buy) $56.49 A 3250 Acquired 2031-06-01 Common Stock (3250) Direct
2021-06-01 Stock Option (right to buy) $56.49 A 5877 Acquired 2031-06-01 Common Stock (5877) Direct
2021-06-01 Restricted Stock Unit $ A 2351 Acquired Common Stock (2351) Direct

Footnotes

F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

F2: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021.

F3: No expiration date for this type of award.

F4: These options, representing the right to purchase a total of 3,250 shares, shall vest and become exercisable in equal monthly installments over three years, beginning on June 1, 2021, contingent upon continued service to the Company.

F5: These options, representing the right to purchase a total of 5,877 shares, shall vest and become exercisable in equal monthly installments beginning on June 1, 2021, and shall become fully vested and exercisable on the earlier of the date of the Company's next annual meeting of shareholders or April 27, 2022, contingent upon continued service to the Company.

F6: These RSUs shall vest on the earlier of June 1, 2022 or the date of the Company's next annual meeting of shareholders, contingent upon continued service to the Company.